4-硝基喹啉-1-氧化物诱导小鼠食管鳞状细胞癌模型的研究进展

国际肿瘤学杂志››2023,Vol. 50››Issue (7): 437-441.doi:10.3760/cma.j.cn371439-20230227-00084

4-硝基喹啉-1-氧化物诱导小鼠食管鳞状细胞癌模型的研究进展

李金歌¹, 李晶², 张振悍¹, 郭建鑫¹, 王景普¹, 吴忠冰³()

¹河北医科大学中西医结合学院，石家庄 050017
²河北医科大学第四医院中医科，石家庄 050019
³河北医科大学中西医结合学院中医基础教研室，石家庄 050017

收稿日期:2023-02-27修回日期:2023-06-07出版日期:2023-07-08发布日期:2023-08-03
通讯作者:吴忠冰，Email： wzb20181103@126.com
基金资助:
国家自然科学基金(82274593);河北医科大学2022年大学生创新性实验计划(USIP2022079)

Research progress of 4-nitroquinoline-1-oxide-induced esophageal squamous cell carcinoma model in mice

Li Jinge¹, Li Jing², Zhang Zhenhan¹, Guo Jianxin¹, Wang Jingpu¹, Wu Zhongbing³()

¹School of Integrated Chinese and Western Medicine，Hebei Medical University，Shijiazhuang 050017，China
²Department of Traditional Chinese Medicine，The Fourth Hospital of Hebei Medical University，Shijiazhuang 050019，China
³Basic Research Office of Traditional Chinese Medicine，School of Integrated Chinese and Western Medicine，Hebei Medical University，Shijiazhuang 050017，China

Received:2023-02-27Revised:2023-06-07Online:2023-07-08Published:2023-08-03
Contact:Wu Zhongbing，Email： wzb20181103@126.com
Supported by:
National Natural Science Foundation of China(82274593);Hebei Medical University 2022 Undergraduate Innovative Experimental Program(USIP2022079)

摘要/Abstract

摘要：

食管鳞状细胞癌（ESCC）是最常见的恶性肿瘤之一，预后较差。4-硝基喹啉-1-氧化物（4NQO）是一种水溶性的喹啉衍生物，在体内可以成功诱导鳞状上皮细胞癌的产生。建立并优化4NQO诱导小鼠ESCC形成的实验方法可以为ESCC研究提供更适宜的原位模型。

李金歌, 李晶, 张振悍, 郭建鑫, 王景普, 吴忠冰. 4-硝基喹啉-1-氧化物诱导小鼠食管鳞状细胞癌模型的研究进展[J]. 国际肿瘤学杂志, 2023, 50(7): 437-441.

Li Jinge, Li Jing, Zhang Zhenhan, Guo Jianxin, Wang Jingpu, Wu Zhongbing. Research progress of 4-nitroquinoline-1-oxide-induced esophageal squamous cell carcinoma model in mice[J]. Journal of International Oncology, 2023, 50(7): 437-441.

参考文献37

[1]	Arnold M, Abnet CC, Neale RE, et al. Global burden of 5 major types of gastrointestinal cancer[J]. Gastroenterology, 2020, 159(1): 335-349.e15. DOI: 10.1053/j.gastro.2020.02.068. doi:S0016-5085(20)30452-2pmid:32247694
[2]	Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(6): 432-443. DOI: 10.1038/s41575-021-00419-3. doi:10.1038/s41575-021-00419-3pmid:33603224
[3]	Ge S, Zhou H, Zhou Z, et al. Serum metabolite profiling of a 4-nitroquinoline-1-oxide-induced experimental oral carcinogenesis model using gas chromatography-mass spectrometry[J]. PeerJ, 2021, 9: e10619. DOI: 10.7717/peerj.10619. doi:10.7717/peerj.10619
[4]	Sagheer SH, Whitaker-Menezes D, Han JYS, et al. 4NQO induced carcinogenesis: a mouse model for oral squamous cell carcinoma[J]. Methods Cell Biol, 2021, 163: 93-111. DOI: 10.1016/bs.mcb.2021.01.001. doi:10.1016/bs.mcb.2021.01.001
[5]	Yamaguchi H, Hiroi M, Mori K, et al. Simultaneous expression of Th1- and Treg-associated chemokine genes and CD4⁺, CD8⁺, and Foxp3⁺cells in the premalignant lesions of 4NQO-induced mouse tongue tumorigenesis[J]. Cancers (Basel), 2021, 13(8): 1835. DOI: 10.3390/cancers13081835. doi:10.3390/cancers13081835
[6]	Parvin M, Rahaman A, Sarkar A, et al. Oroxylum indicum stem bark extract reduces tumor progression by inhibiting the EGFR-PI3K-Akt pathway in an in vivo 4NQO-induced oral cancer model[J/OL]. J Am Nutr Assoc: 1-15. (2022-08-19)[2023-02-20]. https://pubmed.ncbi.nlm.nih.gov/35984397/. DOI: 10.1080/27697061.2022.2107583. doi:10.1080/27697061.2022.2107583
[7]	Liu Z, Su R, Ahsan A, et al. Esophageal squamous cancer from 4NQO-induced mice model: CNV alterations[J]. Int J Mol Sci, 2022, 23(22): 14304. DOI: 10.3390/ijms232214304. doi:10.3390/ijms232214304
[8]	Zhao L, Ma M, Wu H, et al. p-Hydroxylcinnamaldehyde slows the progression of 4NQO-induced oesophageal tumourigenesis via the RhoA-MAPK signaling pathway[J]. Mol Carcinog, 2018, 57(10): 1319-1331. DOI: 10.1002/mc.22847. doi:10.1002/mc.22847
[9]	Aziz Z, Washington MK, Jacobse J, et al. A method for scoring 4-nitroquinoline 1-oxide-induced murine esophageal squamous neoplasia[J]. Vet Pathol, 2023, 60(3): 384-393. DOI: 10.1177/03009858231151381. doi:10.1177/03009858231151381
[10]	Zheng D, Li Z. A sex-dimorphic mouse model of esophageal squamous cell carcinoma[J]. Am J Cancer Res, 2019, 9(2): 429-433. pmid:30906640
[11]	Chen CH, Lu HI, Wang YM, et al. Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma[J]. PLoS One, 2017, 12(2): e0172752. DOI: 10.1371/journal.pone.0172752. doi:10.1371/journal.pone.0172752
[12]	马棫灵. ADH1B和ALDH2风险基因型与饮酒交互作用影响食管鳞癌及其微环境[D]. 北京: 北京协和医学院, 2022. DOI: 10.27648/d.cnki.gzxhu.2022.000258. doi:10.27648/d.cnki.gzxhu.2022.000258
[13]	Chen MF, Lu MS, Hsieh CC, et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma[J]. Cell Oncol (Dordr), 2021, 44(2): 373-384. DOI: 10.1007/s13402-020-00573-x. doi:10.1007/s13402-020-00573-x
[14]	Flashner S, Martin C, Matsuura N, et al. Modeling oral-esophageal squamous cell carcinoma in 3D organoids[J/OL]. J Vis Exp, 2022(190): e64676. (2022-12-23)[2023-02-20]. https://www.jove.com/cn/t/64676/modeling-oral-esophageal-squamous-cell-carcinoma-in-3d-organoids. DOI: 10.3791/64676. doi:10.3791/64676
[15]	于毅. PLCE1基因在C57BL/6转基因小鼠食管癌变中的初步作用机制研究[D]. 石河子: 石河子大学, 2021. DOI: 10.27332/d.cnki.gshzu.2021.000588. doi:10.27332/d.cnki.gshzu.2021.000588
[16]	Nan P, Wang T, Li C, et al. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway[J]. Carcinogenesis, 2020, 41(9): 1263-1272. DOI: 10.1093/carcin/bgz200. doi:10.1093/carcin/bgz200pmid:31783401
[17]	Matrka MC, Cimperman KA, Haas SR, et al. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence[J]. PLoS Genet, 2018, 14(3): e1007227. DOI: 10.1371/journal.pgen.1007227. doi:10.1371/journal.pgen.1007227
[18]	王立群, 靳晶, 刘聪敏, 等. 敲除SLC39A5基因对4-NQO诱发C57BL/6小鼠食管癌模型建立的影响[J]. 肿瘤防治研究, 2018, 45(2): 61-66. DOI: 10.3971/j.issn.1000-8578.2018.17.0809. doi:10.3971/j.issn.1000-8578.2018.17.0809
[19]	Luo Y, Du L, Yao Z, et al. Generation and application of inducible chimeric RNA ASTN2-PAPPA_asknockin mouse model[J]. Cells, 2022, 11(2): 277. DOI: 10.3390/cells11020277. doi:10.3390/cells11020277
[20]	Sawangarun W, Mandasari M, Aida J, et al. Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis[J]. Exp Cell Res, 2018, 372(2): 129-140. DOI: 10.1016/j.yexcr.2018.09.019. doi:S0014-4827(18)30987-Xpmid:30266659
[21]	Li X, Ding F, Wang L, et al. Disruption of enhancer-driven S100A14 expression promotes esophageal carcinogenesis[J]. Cancer Lett, 2022, 545: 215833. DOI: 10.1016/j.canlet.2022.215833. doi:10.1016/j.canlet.2022.215833
[22]	Guha M, Srinivasan S, Sheehan MM, et al. Esophageal 3D orga-noids of MPV17^-/-mouse model of mitochondrial DNA depletion show epithelial cell plasticity and telomere attrition[J]. Oncotarget, 2019, 10(58): 6245-6259. DOI: 10.18632/oncotarget.27264. doi:10.18632/oncotarget.27264
[23]	Sui X, Chen C, Zhou X, et al. Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma[J]. J Exp Clin Cancer Res, 2023, 42(1): 51. DOI: 10.1186/s13046-023-02612-5. doi:10.1186/s13046-023-02612-5
[24]	Li J, Qiu G, Fang B, et al. Deficiency of IL-18 aggravates esophageal carcinoma through inhibiting IFN-γ production by CD8⁺T cells and NK cells[J]. Inflammation, 2018, 41(2): 667-676. DOI: 10.1007/s10753-017-0721-3. doi:10.1007/s10753-017-0721-3
[25]	Zhao Y, Sun J, Li Y, et al. Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT/GSK3β/IL-8 signaling pathway[J]. Acta Pharm Sin B, 2021, 11(9): 2835-2849. DOI: 10.1016/j.apsb.2021.03.009. doi:10.1016/j.apsb.2021.03.009
[26]	夏秀丽, 赵树山, 李云, 等. 黄芪多糖对小鼠食管癌前病变的影响及机制研究[J]. 陕西中医, 2022, 43(8): 1003-1008. DOI: 10.3969/j.issn.1000-7369.2022.08.004. doi:10.3969/j.issn.1000-7369.2022.08.004
[27]	Jia XB, Zhang Q, Xu L, et al. Effect of Malus asiatica Nakai leaf flavonoids on the prevention of esophageal cancer in C57BL/6J mice by regulating the IL-17 signaling pathway[J]. Onco Targets Ther, 2020, 13: 6987-6996. DOI: 10.2147/OTT.S261033. doi:10.2147/OTT.S261033
[28]	Zhu G, Li X, Li J, et al. Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma[J]. J Cancer, 2020, 11(22): 6516-6529. DOI: 10.7150/jca.47111. doi:10.7150/jca.47111pmid:33046973
[29]	Galeano Niño JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer[J]. Nature, 2022, 611(7937): 810-817. DOI: 10.1038/s41586-022-05435-0. doi:10.1038/s41586-022-05435-0
[30]	罗澜, 陈创, 李昕倩, 等. 细菌与乳腺癌的关系[J]. 国际肿瘤学杂志, 2021, 48(5): 292-295. DOI: 10.3760/cma.j.cn371439-20200629-00056. doi:10.3760/cma.j.cn371439-20200629-00056
[31]	张玉双, 于富洋, 吴忠冰, 等. 食管鳞癌原位模型小鼠肠道菌群分析[J]. 中国全科医学, 2022, 25(8): 945-951. DOI: 10.12114/j.issn.1007-9572.2021.01.501. doi:10.12114/j.issn.1007-9572.2021.01.501
[32]	Fraser GE, Jaceldo-Siegl K, Orlich M, et al. Dairy, soy, and risk of breast cancer: those confounded milks[J]. Int J Epidemiol, 2020, 49(5): 1526-1537. DOI: 10.1093/ije/dyaa007. doi:10.1093/ije/dyaa007pmid:32095830
[33]	Tang JWC, Lam WWT, Kwong A, et al. Dietary decision-making in Chinese breast cancer survivors: a qualitative study[J]. Patient Educ Couns, 2022, 105(2): 460-465. DOI: 10.1016/j.pec.2021.05.017. doi:10.1016/j.pec.2021.05.017
[34]	Chen MF, Hsieh CC, Chen PT, et al. Role of nutritional status in the treatment outcome for esophageal squamous cell carcinoma[J]. Nutrients, 2021, 13(9): 2997. DOI: 10.3390/nu13092997. doi:10.3390/nu13092997
[35]	Tanaka T, Kawabata K, Sugie S. 4-nitroquinoline 1-oxide-induced tongue and esophagus carcinogenesis in obese and diabetic TSOD mice[J]. World J Oncol, 2017, 8(4): 97-104. DOI: 10.14740/wjon1038w. doi:10.14740/wjon1038wpmid:29147443
[36]	Ahsan A, Liu Z, Su R, et al. Potential chemotherapeutic effect of selenium for improved canceration of esophageal cancer[J]. Int J Mol Sci, 2022, 23(10): 5509. DOI: 10.3390/ijms23105509. doi:10.3390/ijms23105509
[37]	Wang Y, Liu X, Hu G, et al. EGFR-IL-6 signaling axis mediated the inhibitory effect of methylseleninic acid on esophageal squamous cell carcinoma[J]. Front Pharmacol, 2021, 12: 719785. DOI: 10.3389/fphar.2021.719785. doi:10.3389/fphar.2021.719785